Document Type : Original Article


1 Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, IR Iran.

2 Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

3 MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran


Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), depicted by lymphocytic infiltration and demyelination. MS is associated with the up-regulation of pro-inflammatory and down-regulation of anti-inflammatory cytokines. The purpose of this experimental study was to evaluate the expression level of TGF-β1, TGF-β 2, TGF-β-R1, and TGF-β-R2 mRNAs in peripheral blood mononuclear cells (PBMCs) from MS patients and healthy controls using Real-Time PCR. Our findings indicated that the TGF-β-R1 expression level was 2.25 times higher in controls than in MS patients. Also, a significant correlation between normalized expression of TGF-β-R1 and TGF-β1, or TGF-β2 was observed. Therefore, these genes could likely play an important role in the etiology of MS.


1.Bhise V, Dhib-Jalbut S: Further understanding of the immunopathology of multiple sclerosis: impact on future treatments. Expert review of clinical immunology 2016, 12(10):1069-1089.
2.Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J et al: Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis. Journal of neuroinflammation 2018, 15(1):114.
3.Tian Z, Song Y, Yao Y, Guo J, Gong Z, Wang Z: Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke. Frontiers in genetics 2020, 11:646.
4.Baecher-Allan C, Kaskow BJ, Weiner HL: Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron 2018, 97(4):742-768.
5.Pérez-Cerdá F, Sánchez-Gómez MV, Matute C: The link of inflammation and neurodegeneration in progressive multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders 2016, 1(1):9.
6.Nali LH, Olival GS, Sousa FTG, de Oliveira ACS, Montenegro H, da Silva IT, Dias-Neto E, Naya H, Spangenberg L, Penalva-de-Oliveira AC et al: Whole transcriptome analysis of multiple Sclerosis patients reveals active inflammatory profile in relapsing patients and downregulation of neurological repair pathways in secondary progressive cases. Multiple Sclerosis and Related Disorders 2020, 44:102243.
7.Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, Shoda H, Yamamoto K, Fujio K: Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals. Frontiers in Immunology 2018, 9(1364).
8.Sanjabi S, Oh SA, Li MO: Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. Cold Spring Harbor Perspectives in Biology 2017, 9(6).
9.Lee PW, Severin ME, Lovett-Racke AE: TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis. European Journal of Immunology 2017, 47(3):446-453.
10.Kashima R, Hata A: The role of TGF-β superfamily signaling in neurological disorders. Acta Biochimica et Biophysica Sinica 2017, 50(1):106-120.
11.Voisin A, Damon-Soubeyrand C, Bravard S, Saez F, Drevet JR, Guiton R: Differential expression and localisation of TGF-β isoforms and receptors in the murine epididymis. Scientific reports 2020, 10(1):995.
12.Compston A, Lassmann H, Smith K: Chapter 10 - The neurobiology of multiple sclerosis. In: McAlpine’s Multiple Sclerosis (Fourth Edition). Edited by Wekerle ACCLMMNS. Edinburgh: Churchill Livingstone; 2006: 449-490.
13.Hata A, Chen Y-G: TGF-β Signaling from Receptors to Smads. Cold Spring Harbor Perspectives in Biology 2016, 8(9).
14.Xu J, Wang Y, Jiang H, Sun M, Gao J, Xie A: TGF-β in Mice Ameliorates Experimental Autoimmune Encephalomyelitis in Regulating NK Cell Activity. Cell transplantation 2019, 28(9-10):1155-1160.
15.Nataf S, Guillen M, Pays L: TGFB1-Mediated Gliosis in Multiple Sclerosis Spinal Cords Is Favored by the Regionalized Expression of HOXA5 and the Age-Dependent Decline in Androgen Receptor Ligands. Int J Mol Sci 2019, 20(23).
16.Zhang X, Hamblin MH, Yin KJ: The long noncoding RNA Malat1: Its physiological and pathophysiological functions. RNA biology 2017, 14(12):1705-1714.
17.Vincent V, Tilders F, Van Dam A: Production, regulation and role of nitric oxide in glial cells. Mediators of inflammation 1998, 7(4):239.
18.Meoli EM, Oh U, Grant CW, Jacobson S: TGF-β signaling is altered in the peripheral blood of subjects with multiple sclerosis. Journal of neuroimmunology 2011, 230(1):164-168.
19.Ateke Mousavi N-k, Abbas M, Abdorreza Naser M, Mohammad Reza S-S, Mohammad Reza E, Maryam S, Mina A, Ali Akbar S-Y: Comparison of Cytokine Expression in Multiple Sclerosis Patients and Healthy Volunteers. Acta Medica Iranica 2018, 56(2).
20.Peress NS, Perillo E, Seidman RJ: Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis. Journal of neuroimmunology 1996, 71(1):115-123.
21.Araujo GR, Aglas L, Vaz ER, Machado Y, Huber S, Himly M, Duschl A, Goulart LR, Ferreira F: TGFβ1 mimetic peptide modulates immune response to grass pollen allergens in mice. Allergy 2020, 75(4):882-891.
22.Link J, Söderström M, Olsson T, Höjeberg B, Ljungdahl Å, Link H: Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis. Annals of neurology 1994, 36(3):379-386.
23.Shirvani-Farsani Z, Behmanesh M, Mohammadi SM, Naser Moghadasi A: Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression. Life Sciences 2015, 134:63-67.
24.Shirvani-Farsani Z, Behmanesh M, Sahraian MA: Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients. Journal of the Neurological Sciences 2015, 350(1):18-23.
25.Pahlevan Kakhki M, Rakhshi N, Heidary M, Behmanesh M, Nikravesh A: Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing-remitting multiple sclerosis. J Neurol Sci 2015, 350(1-2):40-45.
26.Heidary M, Rakhshi N, Pahlevan Kakhki M, Behmanesh M, Sanati MH, Sanadgol N, Kamaladini H, Nikravesh A: The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients. J Neurol Sci 2014, 343(1-2):41-45.